Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.
Frairia C, Nicolino B, Secreto C, Messa E, Arrigo G, Busca A, Cerrano M, D'Ardìa S, Dellacasa C, Evangelista A, Freilone R, Giai V, Priolo G, Urbino I, Audisio E. Frairia C, et al. Among authors: arrigo g. Eur J Haematol. 2023 Jun;110(6):696-705. doi: 10.1111/ejh.13952. Epub 2023 Mar 24. Eur J Haematol. 2023. PMID: 36919878
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges.
Olivi M, Di Biase F, Lanzarone G, Arrigo G, Martella F, Apolito V, Secreto C, Freilone R, Bruno B, Audisio E, Ferrero D, Beggiato E, Cerrano M. Olivi M, et al. Among authors: arrigo g. Curr Treat Options Oncol. 2023 Jun;24(6):693-710. doi: 10.1007/s11864-023-01089-w. Epub 2023 Apr 26. Curr Treat Options Oncol. 2023. PMID: 37099265 Review.
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Apolito V, Arrigo G, Vasseur L, Olivi M, Perrone S, Giai V, Secreto C, Di Biase F, De Simone MC, Copia C, Gravetti A, Freilone R, Bruno B, Lanzarone G, Beggiato E, Frairia C, Audisio E, D'Ardia S, Ferrero D, Cerrano M, Ferrara F. Apolito V, et al. Among authors: arrigo g. Br J Haematol. 2023 Nov;203(4):e98-e101. doi: 10.1111/bjh.19022. Epub 2023 Aug 2. Br J Haematol. 2023. PMID: 37533098 No abstract available.
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience.
Urbino I, Secreto C, Apolito V, Olivi M, Arrigo G, Boscaro E, Catania FM, D'Ardia S, Frairia C, Giai V, Freilone R, Bruno B, Lanzarone G, Giaccone L, Busca A, Dellacasa CM, Ferrero D, Audisio E, Cerrano M. Urbino I, et al. Among authors: arrigo g. Leuk Res. 2024 Jan;136:107421. doi: 10.1016/j.leukres.2023.107421. Epub 2023 Nov 18. Leuk Res. 2024. PMID: 38042648 No abstract available.
ROC curve analysis: a useful statistic multi-tool in the research of nephrology.
Roumeliotis S, Schurgers J, Tsalikakis DG, D'Arrigo G, Gori M, Pitino A, Leonardis D, Tripepi G, Liakopoulos V. Roumeliotis S, et al. Among authors: d arrigo g. Int Urol Nephrol. 2024 Mar 26. doi: 10.1007/s11255-024-04022-8. Online ahead of print. Int Urol Nephrol. 2024. PMID: 38530584 Review.
Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation.
Lombardi M, Scaroni F, Gabrielli M, Raffaele S, Bonfanti E, Filipello F, Giussani P, Picciolini S, de Rosbo NK, Uccelli A, Golia MT, D'Arrigo G, Rubino T, Hooshmand K, Legido-Quigley C, Fenoglio C, Gualerzi A, Fumagalli M, Verderio C. Lombardi M, et al. Among authors: d arrigo g. Front Immunol. 2024 Feb 23;15:1331210. doi: 10.3389/fimmu.2024.1331210. eCollection 2024. Front Immunol. 2024. PMID: 38464529 Free PMC article.
289 results